Wei Ling Lau

5.6k total citations · 1 hit paper
85 papers, 3.8k citations indexed

About

Wei Ling Lau is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wei Ling Lau has authored 85 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Nephrology, 18 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wei Ling Lau's work include Dialysis and Renal Disease Management (32 papers), Parathyroid Disorders and Treatments (24 papers) and Chronic Kidney Disease and Diabetes (10 papers). Wei Ling Lau is often cited by papers focused on Dialysis and Renal Disease Management (32 papers), Parathyroid Disorders and Treatments (24 papers) and Chronic Kidney Disease and Diabetes (10 papers). Wei Ling Lau collaborates with scholars based in United States, South Korea and Canada. Wei Ling Lau's co-authors include Nosratola D. Vaziri, Kamyar Kalantar‐Zadeh, Cecilia M. Giachelli, Connie M. Rhee, Csaba P. Kövesdy, Javad Savoj, Mahyar Khazaeli, Yoshitsugu Obi, Elani Streja and Mark Fisher and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Wei Ling Lau

81 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Gut as a Source of Inflammation in Chronic Kidney Disease

2015 388 citations Wei Ling Lau, Kamyar Kalantar‐Zadeh et al. profile →

Peers

Countries citing papers authored by Wei Ling Lau

Since Specialization

Citations

This map shows the geographic impact of Wei Ling Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ling Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ling Lau more than expected).

Fields of papers citing papers by Wei Ling Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Ling Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ling Lau. The network helps show where Wei Ling Lau may publish in the future.

Co-authorship network of co-authors of Wei Ling Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Ling Lau. A scholar is included among the top collaborators of Wei Ling Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Ling Lau. Wei Ling Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating biomarkers of kidney angiomyolipoma and cysts in tuberous sclerosis complex patients 2024 ·iScience ·(unknown), Yujin Chun, Joo‐Hwan Kim, (unknown), Sunhee Jung, Wonsuk Choi, M. Kelly, (unknown), Elizabeth Cassidy, (unknown), Dean J. Aguiar, Wei Ling Lau, (unknown), Moyra Smith, Aimee L. Edinger, Sang‐Guk Lee, Cholsoon Jang, Gina Lee	0
2	A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia 2023 ·BMC Nephrology ·(unknown), (unknown), Luohua Jiang, (unknown), (unknown), Antoney Ferrey, Shahram Lotfipour, Kamyar Kalantar‐Zadeh, Ramy M. Hanna, Wei Ling Lau	10
3	Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury 2023 ·Pharmacology Research & Perspectives ·Mahyar Khazaeli, Ane Cláudia Fernandes Nunes, Yitong Zhao, (unknown), (unknown), Nosratola D. Vaziri, Bhupinder Singh, Wei Ling Lau	7
4	Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA‐CKD 2022 ·Journal of the American Heart Association ·Carlo Briguori, Roy O. Mathew, Zhen Huang, Kreton Mavromatis, LaTonya J. Hickson, Wei Ling Lau, Anoop Mathew, Sandeep Mahajan, David C. Wheeler, Kathleen Claes, Gang Chen, Fernando Nolasco, Gregg W. Stone, Jerome L. Fleg, Mandeep S. Sidhu, Frank W. Rockhold, Glenn M. Chertow, Judith S. Hochman, David J. Maron, Sripal Bangalore	6
5	Association of serum potassium with decline in residual kidney function in incident hemodialysis patients 2022 ·Nephrology Dialysis Transplantation ·(unknown), (unknown), (unknown), (unknown), Wei Ling Lau, Ramy M. Hanna, Yu‐Ji Lee, Yoshitsugu Obi, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Elani Streja	2
6	Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism 2022 ·American Journal of Nephrology ·Melissa Soohoo, Yoshitsugu Obi, Matthew B. Rivara, Scott V. Adams, Wei Ling Lau, Connie M. Rhee, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh, Onyebuchi A. Arah, Rajnish Mehrotra, Elani Streja	6
7	Kidney Function Is Not Related to Brain Amyloid Burden on PET Imaging in The 90+ Study Cohort 2021 ·Frontiers in Medicine ·Wei Ling Lau, Mark Fisher, Evan Fletcher, Charles DeCarli, (unknown), María M. Corrada, Claudia H. Kawas, Annlia Paganini‐Hill	12
8	Controversies: Stroke Prevention in Chronic Kidney Disease 2021 ·Journal of Stroke and Cerebrovascular Diseases ·Wei Ling Lau	2
9	Plant-Dominant Low-Protein Diet for Conservative Management of Chronic Kidney Disease 2020 ·Nutrients ·Kamyar Kalantar‐Zadeh, Shivam Joshi, (unknown), (unknown), Amanda Brown-Tortorici, Meghan Donnelly, (unknown), Wei Ling Lau, Connie M. Rhee, Elani Streja, Ekamol Tantisattamo, Antoney Ferrey, Ramy M. Hanna, (unknown), Shaista Malik, Danh V. Nguyen, Susan T. Crowley, Csaba P. Kövesdy	126
10	Hemodynamic and Laboratory Changes during Incremental Transition from Twice to Thrice-Weekly Hemodialysis 2020 ·Cardiorenal Medicine ·(unknown), (unknown), Yoshitsugu Obi, Hamid Moradi, Elani Streja, Ekamol Tantisattamo, (unknown), Wei Ling Lau, Yongen Chang, (unknown), Joline L.T. Chen, Csaba P. Kövesdy, Connie M. Rhee, Kamyar Kalantar‐Zadeh	1
11	Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree 2020 ·The American Journal of the Medical Sciences ·Grace Choi, Virginia Kimonis, Katherine Hall, Wei Ling Lau	1
12	Parathyroidectomy in the Management of Secondary Hyperparathyroidism 2018 ·Clinical Journal of the American Society of Nephrology ·Wei Ling Lau, Yoshitsugu Obi, Kamyar Kalantar‐Zadeh	137
13	Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients 2016 ·American Journal of Nephrology ·Melissa Soohoo, (unknown), Yoshitsugu Obi, Elani Streja, Connie M. Rhee, Wei Ling Lau, Jialin Wang, Vanessa Ravel, Steven M. Brunelli, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh	27
14	Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients 2016 ·The Journal of Clinical Endocrinology & Metabolism ·Yoshitsugu Obi, Rajnish Mehrotra, Matthew B. Rivara, Elani Streja, Connie M. Rhee, Wei Ling Lau, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh	23
15	Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis 2015 ·Journal of the American Society of Nephrology ·Matthew B. Rivara, Vanessa Ravel, Kamyar Kalantar‐Zadeh, Elani Streja, Wei Ling Lau, Allen R. Nissenson, Bryan Kestenbaum, Ian H. de Boer, Jonathan Himmelfarb, Rajnish Mehrotra	68
16	Impact of Age, Race and Ethnicity on Dialysis Patient Survival and Kidney Transplantation Disparities 2014 ·American Journal of Nephrology ·Connie M. Rhee, Paungpaga Lertdumrongluk, Elani Streja, Jongha Park, Hamid Moradi, Wei Ling Lau, Keith C. Norris, Allen R. Nissenson, Alpesh Amin, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh	53
17	Clinical Uses of 1-Alpha-Hydroxy-Ergocalciferol 2014 ·Current Vascular Pharmacology ·Jongha Park, Connie M. Rhee, Wei Ling Lau, Kamyar Kalantar‐Zadeh	8
18	High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease 2014 ·PLoS ONE ·Nosratola D. Vaziri, (unknown), Wei Ling Lau, Mahyar Khazaeli, Sohrab Nazertehrani, Seyed H. Farzaneh, Dorothy A. Kieffer, Sean H. Adams, Roy J. Martin	226
19	Impact of age on survival predictability of bone turnover markers in hemodialysis patients 2013 ·Nephrology Dialysis Transplantation ·Paungpaga Lertdumrongluk, Wei Ling Lau, Jongha Park, Connie M. Rhee, Csaba P. Kövesdy, Kamyar Kalantar‐Zadeh	31
20	Core histone genes of Giardia intestinalis: genomic organization, promoter structure and expression. 2008 ·BMC Health Services Research ·(unknown), (unknown), Wei Ling Lau, H. Ritter, (unknown), Melissa M. Page	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact